50 million single-shot doses of covid-19 vaccines will be released to Nigeria before the end of December 2021 to be administered on Nigerians, even as the pandemic continues to take its toils on Nigerians.
This is coming from the Regional Chief Operating Officer, African Export-Import Bank (Afreximbank), Anglophone West Africa, Abdoulaye Kone who stated that the organisation was believing that by January 2022, the number of those vaccinated will hit 25million.
“By January 2022, the number of vaccines being released will be in excess of 25million per month”, he posited.
According to him, the arrival of 177,600 doses of Johnson and Johnson COVID-19 vaccine to Nigeria followed an agreement signed on March 28, 2021, with all African Union member states, through the African Vaccine Acquisition Trust (AVAT), set up in November 2020, by the African Union.
“It is worthy to note that Nigeria will receive in August, a total of 1,173,132 doses of J and J vaccine, adding that by the agreement, Africa is expected to have access to 220 million doses of the Johnson and Johnson single-shot Covid-19 vaccine, with potential to order an additional 180 million doses.
Regional Chief Operating Officer, Afreximbank further stated that the Johnson and Johnson vaccines rollout began in August 2021, with Togo being the first African country to receive the shipment from the African Union AVAT initiative on August 5.
He quoted Prof Benedict Oramah, President and Chairman of the Birad of Afreximbank, as declaring that “The very low access to vaccines has exposed Africa to a devastating third and fourth waves of covid-19.
“Death rates are rising, and economies are becoming increasingly vulnerable. We are encouraged by the successful commencement of this vaccine roll out, which will help contain the spread of the virus and protect lives and livelihood. Afreximbank is pleased to have contributed in the historic procurement of vaccines by AVAT”.
Executive Director and Chief Executive Officer of National Primary Healthcare Development Agency, Dr Faisal Shuaib commended Afreximbank, assuring the vaccine would be stored at the temperature of plus 2 degrees celsius to plus 8 degree celsius.
Dr Shuaib disclosed that the doses would be optimized to those living in high risk areas, riverine areas and those vulnerable to move around.
He maintained that different vaccines have the same effect for tackling covid-19, and J and J vaccine is a single-shot dose. The NPHDA boss charged Nigerians to go to the nearest healthcare centre to get vaccinated.
In their separate comments, Representatives of WHO, UNICEF and Africa CDC lauded Afreximbank, J and J, and development partners over the breakthrough in supplying the vaccine to Nigeria, and Africa in general.
Uche Nwosu is a two time Shell Petroleum PLC award winner in the year 2000;
He won the Shell Award on Investigative Journalism and Environmental Cleanliness.